Vitamin D and inflammation

Joint Bone Spine

Volumn 77, Issue 6, 2010, Pages 552-557

  Guillot, Xavier ^a,b   Semerano, Luca ^a,b   Saidenberg Kermanac'h, Nathalie ^a,b   Falgarone, Géraldine ^a,b   Boissier, Marie Christophe ^a,b  

^a UNIVERSITÉ PARIS 13   (France)

^b AVICENNE HOSPITAL   (France)

Author keywords

1 hydroxylase; 1,25 dihydroxyvitamin D3; 25 hydroxylase; B cell; Dendritic cell; Macrophage; T cell; Vitamin D receptor

Indexed keywords

CALCIDIOL 1 MONOOXYGENASE; CALCITRIOL; CALCIUM; COLECALCIFEROL; ERGOCALCIFEROL; VITAMIN D;

B LYMPHOCYTE; CALCIUM HOMEOSTASIS; CLINICAL TRIAL; CROHN DISEASE; DENDRITIC CELL; DIABETES MELLITUS; ENZYME METABOLISM; HUMAN; IMMUNOMODULATION; INFLAMMATION; MACROPHAGE; MULTIPLE SCLEROSIS; NONHUMAN; RHEUMATOID ARTHRITIS; SHORT SURVEY; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; VITAMIN BLOOD LEVEL; VITAMIN D METABOLISM; VITAMIN SUPPLEMENTATION;

ANIMALS; B-LYMPHOCYTES; CALCIUM; CALCIUM SIGNALING; CELL SURVIVAL; CELLS, CULTURED; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; HOMEOSTASIS; HUMANS; IMMUNE SYSTEM; IMMUNOMODULATION; INFLAMMATION; MACROPHAGES; T-LYMPHOCYTES; VITAMIN D;

EID: 78649907037     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbspin.2010.09.018     Document Type: Short Survey

References (60)

1. Holick M.F. Vitamin D deficiency. N Engl J Med 2007, 357:266-281.
2. Audran M., Briot K. Critical reappraisal of vitamin D deficiency. Joint Bone Spine 2010, 77:115-119.
3. Souberbielle J.C., Friedlander G., Kahan A., et al. Evaluating vitamin D status. Implications for preventing and managing osteoporosis and other chronic diseases. Joint Bone Spine 2006, 73:249-253.
4. Maruotti N., Cantatore F.P. Vitamin D and the immune system. J Rheumatol 2010, 37(3):1-5.
5. Arnson Y., Amital H., Shoenfeld Y. Vitamin D and autoimmunity: new aetiological and therapeutic considerations. Ann Rheum Dis 2007, 66:1137-1142.
6. Mora J.R., Iwata M., von Andrian U.H. Vitamin effects on the immune system: vitamins A and D take centre stage. Nat Rev Immunol 2008, 8:685-698.
7. Sigmundsdottir H., Pan J., Debes G.F., et al. DCs metabolize sunlight-induced vitamin D3 to 'program' T cell attraction to the epidermal chemokine CCL27. Nat Immunol 2007, 8:285-293.
8. Hewison M., Freeman L., Hughes S.V., et al. Differential regulation of vitamin D receptor and its ligand in human monocyte-derived dendritic cells. J Immunol 2003, 170:5382-5390.
9. Provvedini D.M., Tsoukas C.D., Deftos L.J., et al. 1,25-dihydroxyvitamin D3 receptors in human leukocytes. Science 1983, 221:1181-1183.
10. Mathieu C., van Etten E., Gysemans C., et al. In vitro and in vivo analysis of the immune system of vitamin D receptor knockout mice. J. Bone Miner Res 2001, 16:2057-2065.
11. Wittke A., Weaver V., Mahon B.D., et al. Vitamin D receptor-deficient mice fail to develop experimental allergic asthma. J Immunol 2004, 173:3432-3436.
12. Helming L., Bose J., Ehrchen J., et al. 1alpha,25-dihydroxyvitamin D3 is a potent suppressor of interferon gamma-mediated macrophage activation. Blood 2005, 106:4351-4358.
13. Dickie L.J., Church L.D., Coulthard L.R., et al. Vitamin D3 down-regulates intracellular Toll-like receptor 9-induced IL-6 production in human monocytes. Rheumatology (Oxford) 2010, 49:1466-1471.
14. Liu P.T., Stenger S., Li H., et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006, 311:1770-1773.
15. Griffin M.D., Lutz W., Phan V.A., et al. Dendritic cell modulation by 1 alpha,25 dihydroxyvitamin D3 and its analogs: a vitamin D receptor-dependant pathway that promotes a persistent state of immaturity in vitro and in vivo. Proc Natl Acad Sci U S A 2001, 98:6800-6805.
16. Gauzzi M.C., Purificato C., Donato K., et al. Suppressive effect of 1 alpha,25-dihydroxyvitamin D3 on type I IFN-mediated monocyte differenciation into dendritic cells: impairment of functional activities and chemotaxis. J Immunol 2005, 174:270-276.
17. Almerighi C., Sinistro A., Cavazza A., et al. 1a,25-dihydroxyvitamin D3 inhibits CD40L-induced pro-inflammatory and immunomodulatory activity in human monocytes. Cytokine 2009, 45:190-197.
18. Boissier M.C., Assier E., Biton J., et al. Regulatory T cells (Treg) in rheumatoid arthritis. Joint Bone Spine 2009, 76:10-14.
19. Daniel C., Sartory N.A., Zahn N., et al. Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile. J Pharmacol Exp Ther 2008, 324:23-33.
20. Gregori S., Casorati M., Amuchastegui S., et al. Regulatory T cells induced by 1 alpha,25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance. J Immunol 2001, 167:1945-1953.
21. Mahon B.D., Wittke A., Weaver V., et al. The targets of vitamin D depend on the differentiation and activation status of CD4 positive T cells. J Cell Biochem 2003, 89:922-932.
22. Boonstra A., Barrat F.J., Crain C., et al. 1alpha,25 dihydroxyvitamin D3 has a direct effect on naive CD4+ T cells to enhance the development of Th2 cells. J Immunol 2001, 167:4974-4980.
23. Barrat F.J., Cua D.J., Boonstra A., et al. In vitro generation of interleukin 10-producing regulatory CD4+ T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1) and Th2-inducing cytokines. J Exp Med 2002, 195:603-616.
24. Froicu M., Weaver V., Wynn T.A., et al. A crucial role for the vitamin D receptor in experimental inflammatory bowel diseases. Mol Endocrinol 2003, 17:2386-2392.
25. Jeffery L.E., Burke F., Mura M., et al. 1,25-dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3. J Immunol 2009, 183:5458-5467.
26. Meehan M.A., Kerman R.H., Lemire J.M. 1,25-dihydroxyvitamin D3 enhances the generation of nonspecific suppressor cells while inhibiting the induction of cytotoxic cells in a human MLR. Cell Immunol 1992, 140:400-409.
27. Chen S., Sims G.P., Chen X.X., et al. Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. J Immunol 2007, 179:1634-1647.
28. Aguado P., del Campo M.T., Garces M.V., et al. Low vitamin D levels in outpatient postmenopausal women from a rheumatology clinic in Madrid, Spain: their relationship with bone mineral density. Osteoporos Int 2000, 11:739-744.
29. Merlino L.A., Curtis J., Mikuls T.R., et al. Vitamin D intake is inversely associated with rheumatoid arthritis: results from the Iowa Women's Health Study. Arthritis Rheum 2004, 50:72-77.
30. Nielen M.M., van Schaardenburg D., Lems W.F., et al. Vitamin D deficiency does not increase the risk of rheumatoid arthritis: comment on the article by Merlino and al. Arthritis Rheum 2006, 54:3719-3720.
31. Costenbader K.H., Feskanich D., Holmes M., et al. Vitamin D intake and risks of lupus erythematosus and rheumatoid arthritis in women. Ann Rheum Dis 2008, 67:530-535.
32. Patel S., Farragher T., Berry J., et al. Association between serum vitamin D metabolite levels and disease activity in patients with early inflammatory polyarthritis. Arthritis Rheum 2007, 56:2143-2149.
33. Hein G., Oelzner P. Vitamin D metabolites in rheumatoid arthritis: findings-hypotheses-consequences. Z Rheumatol 2000, 59:28-32.
34. Andjelkovic Z., Vojinovik J., Pejnovic N., et al. Disease-modifying and immunomodulatory effects of high dose 1 alpha (OH) D3 in rheumatoid arthritis patients. Clin Exp Rheumatol 1999, 17:453-456.
35. Cantorna M.T., Hayes C.E., DeLuca H.F. 1,25 Dihydroxycholecalciferol inhibits the progression of arthritis in murine models of human arthritis. J Nutr 1998, 128:68-72.
36. Boissier M.C., Chiocchia G., Fournier C. Combination of cyclosporine A and calcitriol in the treatment of adjuvant arthritis. J Rheumatol 1992, 19:754-757.
37. Tetlow L.C., Smith S.J., Mawer E.B., et al. Vitamin D receptors in the rheumatoid lesion: expression by chondrocytes, macrophages and synoviocytes. Ann Rheum Dis 1999, 58:118-121.
38. Inaba M., Yukioka K., Furumitsu Y., et al. Positive correlation between levels of IL-1 or IL-2 and 1,25(OH)2D/25(OH)D ratio in synovial fluid of patients with rheumatoid arthritis. Life Sci 1997, 61:977-998.
39. Podolsky D.K. Inflammatory bowel disease (1). N Engl J Med 1991, 325:928-937.
40. Jahnsen J., Falch J.A., Mowinckel P., et al. Vitamin D status, parathyroid hormone and bone mineral density in patients with inflammatory bowel disease. Scand J Gastroenterol 2002, 37:192-199.
41. Lamb E.J., Wong T., Smith D.J., et al. Metabolic bone disease is present at diagnosis in patients with inflammatory bowel disease. Aliment Pharmacol Ther 2002, 16:1895-1902.
42. Jorgensen S.P., Agnholt J., Glerup H., et al. Clinical trial: vitamin D3 treatment in Crohn's disease - a randomized double-blind placebo-controlled study. Aliment Pharmacol Ther 2010, 32:377-383.
43. Daniel C., Radeke H.H., Sartory N.A., et al. The new low calcemic vitamin D analog 22-ene-25-oxa-vitamin D prominently ameliorates Th1-mediated colitis in mice. J Pharmacol Exp Ther 2006, 319:622-631.
44. Alarcon G.S., Friedman A.W., Straaton K.V., et al. Systemic lupus erythematosus in three ethnic groups: III. A comparison of characteristics early in the natural history of the LUMINA cohort. Lupus in Minority populations: Nature vs. Nurture. Lupus 1999, 8:197-209.
45. Kamen D.L., Cooper G.S., Bouali H., et al. Vitamin D deficiency in systemic lupus erythematosus. Autoimmun Rev 2006, 5:114-117.
46. Huisman A.M., White K.P., Algra A., et al. Vitamin D levels in women with systemic lupus erythematosus and fibromyalgia. J Rheumatol 2001, 28:2535-2539.
47. Amital H., Szekanecz Z., Szücs G., et al. Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: is it time to routinely supplement patients with SLE with vitamin D?. Ann Rheum Dis 2010, 69:1155-1157.
48. Zold E., Szodoray P., Gaal J., et al. Vitamin D deficiency in undifferentiated connective tissue disease. Arthritis Res Ther 2008, 10:R123.
49. Lemire J.M., Ince A., Takashima M. 1,25-Dihydroxyvitamin D3 attenuates the expression of experimental murine lupus of MRL/l mice. Autoimmunity 1992, 12:143-148.
50. Vaisberg M.W., Kaneno R., Franco M.F., et al. Influence of cholecalciferol (vitamin D3) on the course of experimental systemic lupus erythematosus in F1 (NZB x W) mice. J Clin Lab Anal 2000, 14:91-96.
51. Hypponen E., Laara E., Reunanen A., et al. Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet 2001, 358:1500-1503.
52. Mathieu C., Laureys J., Sobis H., et al. 1,25-Dihydroxyvitamin D3 prevents insulitis in NOD mice. Diabetes 1992, 41:1491-1495.
53. Gregori S., Giarratana N., Smiroldo S., et al. 1 alpha,25-dihydroxyvitamin D(3) analog enhances regulatory T-cells and arrests autoimmune diabetes in NOD mice. Diabetes 2002, 51:1367-1374.
54. Hayes C.E., Cantorna M.T., DeLuca H.F. Vitamin D and multiple sclerosis. Proc Soc Exp Biol Med 1997, 216:21-27.
55. Nieves J., Cosman F., Herbert J., et al. High prevalence of vitamin D deficiency and reduced bone mass in multiple sclerosis. Neurology 1994, 44:1687-1692.
56. Munger K.L., Zhang S.M., O'Reilly E., et al. Vitamin D intake and incidence of multiple sclerosis. Neurology 2004, 62:60-65.
57. Goldberg P., Fleming F.C., Picard E.H. Multiple sclerosis: decreased relapse rate through dietary supplementation with calcium, magnesium and vitamin D. Med Hypotheses 1986, 21:193-200.
58. Spach K.M., Nashold F.E., Dittel B.N., et al. IL-10 signaling is essential for 1,25-dihydroxyvitamin D3-mediated inhibition of experimental autoimmune encephalomyelitis. J Immunol 2006, 177:6030-6037.
59. Cantorna M.T., Humpal-Winter J., DeLuca H.F. Dietetary calcium is a major factor in 1,25-Dihydroxycholecalciferol suppression of experimental autoimmune encephalomyelitis in mice. J Nutr 1999, 129:1966-1971.
60. Boissier M.C., Assier E., Falgarone G., et al. Shifting the imbalance from Th1/Th2 to Th17/treg: the changing rheumatoid arthritis paradigm. Joint Bone Spine 2008, 75:373-375.